Cases & Deals

  • Home
  • Practices
  • U.S. therapeutics company uses European corporate intelligence for patent opposition proceedings

Share

U.S. therapeutics company uses European corporate intelligence for patent opposition proceedings

August 2011

Client(s) U.S. therapeutics company

Jones Day provided strategic advice to a U.S. therapeutics company for defending a key patent in European opposition proceedings. Using private investigators, several scientists were located and signed up to provide expert evidence on important prior art publications to be used in defending validity of the patent.

Contacts

Before sending, please note:

Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.